Report overview
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
This report aims to provide a comprehensive presentation of the global market for Continuous Subcutaneous Insulin Infusion Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Subcutaneous Insulin Infusion Therapy. This report contains market size and forecasts of Continuous Subcutaneous Insulin Infusion Therapy in global, including the following market information:
Global Continuous Subcutaneous Insulin Infusion Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Continuous Subcutaneous Insulin Infusion Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Normal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Continuous Subcutaneous Insulin Infusion Therapy include Medtronic, Roche, SOOIL, Tandem Diabetes care, Insulet Corp, Valeritas and Microport, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Continuous Subcutaneous Insulin Infusion Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Subcutaneous Insulin Infusion Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Continuous Subcutaneous Insulin Infusion Therapy Market Segment Percentages, by Type, 2022 (%)
Normal
Patch Pump
Global Continuous Subcutaneous Insulin Infusion Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Continuous Subcutaneous Insulin Infusion Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Continuous Subcutaneous Insulin Infusion Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Continuous Subcutaneous Insulin Infusion Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Subcutaneous Insulin Infusion Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Continuous Subcutaneous Insulin Infusion Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport
Outline of Major Chapters:
Chapter 1: Introduces the definition of Continuous Subcutaneous Insulin Infusion Therapy, market overview.
Chapter 2: Global Continuous Subcutaneous Insulin Infusion Therapy market size in revenue.
Chapter 3: Detailed analysis of Continuous Subcutaneous Insulin Infusion Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Continuous Subcutaneous Insulin Infusion Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
